TMPRSS2‐ERG fusions linked to prostate cancer racial health disparities: A focus on Africa

The expression profile and heterogeneity analysis of ERG in 633 consecutive prostate cancers from a single center

(2019) Ling Nie et al.   PROSTATE

Whole Genome Sequencing Reveals Elevated Tumor Mutational Burden and Initiating Driver Mutations in African Men with Treatment-Naive, High-Risk Prostate Cancer

(2018) Weerachai Jaratlerdsiri et al.   CANCER RESEARCH

Prostate cancer genomics and racial health disparity

(2018) Vanessa M. Hayes et al.   Oncotarget

Frequent PTPRK-RSPO3 fusions and RNF43 mutations in colorectal traditional serrated adenoma

(2016) Shigeki Sekine et al.   JOURNAL OF PATHOLOGY

Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data

(2016) Claire L Vale et al.   LANCET ONCOLOGY

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

TMPRSS2-ERG Fusions Are Strongly Linked to Young Patient Age in Low-grade Prostate Cancer

(2014) Stefan Steurer et al.   EUROPEAN UROLOGY

Clinical presentation of prostate cancer in Black South Africans

(2014) Elizabeth A. Tindall et al.   PROSTATE

Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer

(2010) M.-L. Zhu et al.   CANCER RESEARCH

TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of caucasian, african-american and japanese patients

(2010) Cristina Magi-Galluzzi et al.   PROSTATE

Starving the Addiction: New Opportunities for Durable Suppression of AR Signaling in Prostate Cancer

(2009) K. E. Knudsen et al.   CLINICAL CANCER RESEARCH

Induced Chromosomal Proximity and Gene Fusions in Prostate Cancer

(2009) R.-S. Mani et al.   SCIENCE